Fig. 2.

Chemosensitivity (pCR) per subtype classification (n = 403). One patient was classified as HER2 type, but this patient did not have a pCR. pCR pathological complete response, HER2 human epidermal growth factor receptor, BP BluePrint, HR+ hormone receptor-positive, IHC immunohistochemistry, FISH fluorescence in situ hybridization